3-(Cyclopropylaminocarbonyl)-5-nitrophenylboronic acid: Lab Protocol

3-(Cyclopropylaminocarbonyl)-5-nitrophenylboronic acid is a bifunctional arylboronic acid reagent featuring both a nitro group and a cyclopropyl amide substituent, making it a versatile building block for Suzuki–Miyaura cross-coupling reactions and medicinal chemistry syntheses.

Product Name

3-(Cyclopropylaminocarbonyl)-5-nitrophenylboronic acid

SKU

C187373

Functional Groups

Boronic acid, nitro, cyclopropyl amide

Primary Application

Suzuki–Miyaura cross-coupling; medicinal chemistry building block

Storage Recommendation

Store in a cool, dry place, away from moisture and light

Handling Precaution

Use in a well-ventilated area; avoid inhalation and skin contact

Overview and Chemical Properties

3-(Cyclopropylaminocarbonyl)-5-nitrophenylboronic acid (Aladdin SKU: C187373) is an arylboronic acid bearing two additional functional groups on the phenyl ring: a nitro (–NO₂) group at the 5-position and a cyclopropylaminocarbonyl (cyclopropyl amide) group at the 3-position. The boronic acid moiety (–B(OH)₂) provides the reactive handle for palladium-catalysed cross-coupling chemistry, particularly Suzuki–Miyaura reactions, while the nitro and amide substituents introduce both electronic modulation and opportunities for further downstream functionalisation. This compound serves as a versatile synthetic intermediate in pharmaceutical and agrochemical research programmes.

Materials and Equipment Required

• 3-(Cyclopropylaminocarbonyl)-5-nitrophenylboronic acid (C187373)
• Palladium catalyst (e.g., Pd(PPh₃)₄ or Pd(dppf)Cl₂) — select based on substrate requirements
• Inorganic base (e.g., K₂CO₃, Cs₂CO₃, or Na₂CO₃)
• Anhydrous solvent system (e.g., DMF/water, dioxane/water, or toluene/EtOH/water)
• Aryl halide or pseudohalide coupling partner
• Schlenk line or glovebox for inert-atmosphere work
• Analytical balance, round-bottom flasks, magnetic stir bars, reflux condenser
• Thin-layer chromatography (TLC) plates and UV lamp for reaction monitoring
• Rotary evaporator and column chromatography materials for product isolation

Note: All reagent quantities should be calculated based on the specific scale of the intended reaction. Consult primary literature for optimised catalyst loadings appropriate to your substrate.

Step-by-Step Protocol for Suzuki–Miyaura Coupling

1. Preparation of reaction vessel: Oven-dry a round-bottom flask and cool under inert gas (N₂ or Ar). Add a magnetic stir bar.
2. Charging reagents: Weigh and add the aryl halide coupling partner, 3-(Cyclopropylaminocarbonyl)-5-nitrophenylboronic acid (C187373; typically 1.0–2.0 equiv relative to the aryl halide), and the palladium catalyst (typically 1–5 mol%) to the flask under inert atmosphere.
3. Addition of base and solvent: Add the selected inorganic base (typically 2.0–3.0 equiv) followed by the degassed solvent mixture. Ensure all solids are well suspended or dissolved.
4. Degassing: If not performed previously, degas the reaction mixture by three freeze–pump–thaw cycles or by sparging with inert gas for at least 15 minutes.
5. Heating: Fit the flask with a reflux condenser under inert atmosphere and heat with stirring to the required temperature (typically 80–100 °C) for the designated reaction time (typically 2–16 hours). Monitor progress by TLC or LC-MS.
6. Work-up: Allow the reaction to cool to room temperature. Dilute with ethyl acetate and wash sequentially with water and brine. Dry the organic layer over anhydrous Na₂SO₄, filter, and concentrate under reduced pressure.
7. Purification: Purify the crude product by silica gel column chromatography or recrystallisation, selecting an appropriate eluent system guided by TLC.
8. Characterisation: Confirm product identity and purity by ¹H NMR, ¹³C NMR, and HRMS or LC-MS.

Important: Specific reaction conditions (temperature, time, catalyst, base, and solvent) must be optimised for each individual substrate combination. The parameters above are general guidelines based on standard Suzuki–Miyaura methodology.

Safety, Storage and Handling

Safety: 3-(Cyclopropylaminocarbonyl)-5-nitrophenylboronic acid contains a nitro group and should be treated as a potential irritant. Always wear appropriate personal protective equipment (PPE) including nitrile gloves, safety glasses, and a laboratory coat. Avoid inhalation of dust or aerosols; handle in a well-ventilated fume hood. Consult the Safety Data Sheet (SDS) supplied with the product before use.

Storage: Store in a tightly sealed container in a cool (2–8 °C or as specified on the product label), dry location, protected from light and moisture. Boronic acids are susceptible to protodeboronation and oxidation under prolonged exposure to air and moisture; minimise such exposure during weighing.

Disposal: Dispose of waste containing this compound in accordance with local, regional, and national environmental regulations.

Troubleshooting and Optimisation Tips

• Low conversion: Ensure complete removal of oxygen from the reaction system; increase catalyst loading; verify base compatibility with the substrate; consider switching to a more reactive palladium catalyst system.
• Homocoupling by-products: Reduce the equivalents of boronic acid; improve deoxygenation; lower reaction temperature.
• Protodeboronation: Avoid excess base or prolonged reaction times at high temperature; consider using milder conditions or alternative boronic ester forms.
• Poor solubility of boronic acid: Switch to a co-solvent system (e.g., adding DMSO or increasing water content); gentle warming before addition may assist dissolution.
• Decomposition of starting material: Check integrity of stored material; re-dry if moisture uptake is suspected; use freshly opened material where possible.

Frequently asked questions

What is 3-(Cyclopropylaminocarbonyl)-5-nitrophenylboronic acid used for?

This compound is primarily used as a boronic acid coupling partner in palladium-catalysed Suzuki–Miyaura cross-coupling reactions to construct biaryl and heteroaryl scaffolds. Its nitro and cyclopropyl amide substituents make it particularly useful as a functionalised building block in medicinal chemistry and drug discovery programmes.

How should 3-(Cyclopropylaminocarbonyl)-5-nitrophenylboronic acid be stored to maintain stability?

The compound should be stored in a tightly sealed container in a cool, dry place away from moisture and direct light, ideally at 2–8 °C or as specified on the product label. Boronic acids are susceptible to protodeboronation and oxidation upon prolonged exposure to air and moisture, so containers should be resealed promptly after use.

What palladium catalysts are compatible with this boronic acid in Suzuki–Miyaura reactions?

Commonly used palladium catalysts compatible with arylboronic acids of this type include Pd(PPh₃)₄, Pd(dppf)Cl₂, Pd(OAc)₂ with a phosphine ligand, and Pd₂(dba)₃. The optimal catalyst choice depends on the specific aryl halide coupling partner and the reaction conditions; optimisation is recommended for each new substrate combination.

Can the nitro group in this compound be reduced after the coupling reaction?

Yes, the nitro group can be reduced to an amine using standard methods such as catalytic hydrogenation (e.g., H₂/Pd-C), iron or zinc reduction in acidic media, or sodium dithionite reduction. This allows access to aniline derivatives, which are valuable intermediates in pharmaceutical synthesis. Care should be taken to ensure compatibility of the reduction conditions with all other functional groups present in the molecule.

References

1. Miyaura, N.; Suzuki, A. Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds. Chem. Rev. 1995, 95, 2457–2483. doi:10.1021/cr00039a007
2. Hall, D. G. (Ed.) Boronic Acids: Preparation and Applications in Organic Synthesis, Medicine and Materials, 2nd ed.; Wiley-VCH: Weinheim, 2011.
3. Lennox, A. J. J.; Lloyd-Jones, G. C. Selection of boron reagents for Suzuki–Miyaura coupling. Chem. Soc. Rev. 2014, 43, 412–443. doi:10.1039/C3CS60197H

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.